NYSE:BDX
NYSE:BDXMedical Equipment

Does Becton Dickinson’s Recent Slide Create an Opportunity for Long Term Investors in 2025?

Wondering if Becton Dickinson is quietly turning into a value opportunity while most investors are looking elsewhere? Let us walk through what the current share price is really baking in. The stock now trades around $195.59, down 2.2% over the last week and 13.6% year to date, even though it has managed a modest 1.5% gain over the last month. Recent interest has been driven by Becton Dickinson sharpening its focus on higher margin medical technologies and continuing to integrate past...
NYSE:BCC
NYSE:BCCTrade Distributors

Boise Cascade (BCC): Assessing Valuation After a Steep Share Price Pullback

Boise Cascade (BCC) has been grinding through a tougher stretch this year, with the stock down sharply from its highs, and that slide now has value focused investors taking a closer look. See our latest analysis for Boise Cascade. Over the past year, that tougher housing and construction backdrop has weighed heavily, with a year to date share price return of minus 36.2 percent and a one year total shareholder return of minus 38.2 percent. Even so, the five year total shareholder return is...
NasdaqGM:VITL
NasdaqGM:VITLFood

The Bull Case For Vital Farms (VITL) Could Change Following Revised 2025 Guidance And 2026 Outlook

Earlier in December 2025, Vital Farms updated its 2025 earnings guidance to US$755 million–US$765 million in net revenue, citing temporary ordering disruptions following an ERP transition, and issued a 2026 outlook of US$930 million–US$950 million in net revenue. The company’s guidance reset and longer-term revenue ambitions highlight a tension between short-term demand softness in premium eggs and management’s confidence in capacity expansion and brand-driven growth. Next, we’ll explore how...
NasdaqGS:IMVT
NasdaqGS:IMVTBiotechs

How Investors Are Reacting To Immunovant (IMVT) $550 Million Follow-On Equity Raise And Dilution

In December 2025, Immunovant, Inc. completed a follow-on equity offering of approximately US$550.2 million, issuing 26,200,000 common shares at US$21 each, with a small discount on part of the deal. This sizeable capital raise, coming through both a completed and a filed follow-on offering, materially expands Immunovant’s financial resources while increasing equity dilution for existing shareholders. We’ll now examine how this large follow-on equity raise, and the resulting balance between...
NasdaqGS:KLAC
NasdaqGS:KLACSemiconductor

KLA (KLAC): Assessing Valuation After Jefferies’ Top Pick Call and Earnings Beat-Driven Rally

KLA (KLAC) just got a confidence boost after Jefferies tagged it as a top pick for 2026, following earnings that topped expectations and sparked a wave of more upbeat analyst views. See our latest analysis for KLA. That call from Jefferies comes on top of a powerful run, with a roughly 13.5% 1 month share price return feeding into a near doubling of the year to date share price and a massive five year total shareholder return above 400%. This suggests momentum is still very much on KLA’s...
NasdaqGM:VCEL
NasdaqGM:VCELBiotechs

How Investors Are Reacting To Vericel (VCEL) Reaffirmed Guidance And MACI-Focused Growth Narrative

In recent days, Vericel reported higher fiscal Q3 2025 revenue and reaffirmed its full-year revenue and profitability guidance, highlighting expected growth in its MACI product line alongside stable gross and adjusted EBITDA margins. At the same time, multiple research firms, including Truist Securities and Canaccord Genuity, reiterated positive ratings on Vericel, signaling continued institutional confidence despite higher operating expenses tied to headcount growth and new manufacturing...
NYSE:SRFM
NYSE:SRFMAirlines

Surf Air Mobility (SRFM): Revisiting Valuation After Q3 Beat, Upgraded Outlook and New Palantir Partnership

Surf Air Mobility (SRFM) is back on traders radar after Q3 results topped its own revenue guidance, and management raised the full year outlook while also unveiling a Palantir partnership that includes a sector specific exclusivity agreement. See our latest analysis for Surf Air Mobility. Even with the Palantir deal and stronger Q3 narrative giving the story fresh energy, Surf Air Mobility’s share price at $1.83 still reflects a bruising year. A sharp 90 day share price return of minus 58.97...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

How Liquidia’s Reaffirmed Analyst Support and Revenue Momentum Will Impact Liquidia (LQDA) Investors

In recent days, Wells Fargo’s Benjamin Burnett reaffirmed a Buy rating on Liquidia Technologies, aligning with a broader analyst consensus of Strong Buy and reflecting confidence following the company’s latest quarterly update. Liquidia’s strong year-over-year revenue growth has reinforced perceptions that the company is building operational momentum, which may be influencing how analysts and investors frame its long-term potential. We will now examine how the reaffirmed Buy rating,...
NYSE:FE
NYSE:FEElectric Utilities

FirstEnergy (FE) valuation check as $276 million House Bill 6 settlement deal seeks to clear regulatory overhang

FirstEnergy (FE) is back in the spotlight after agreeing to a roughly $276 million settlement tied to the House Bill 6 scandal, a deal that could finally clear major regulatory overhangs for investors. See our latest analysis for FirstEnergy. The settlement headlines land after a choppy few months, with a roughly 5.7% 1 month share price return decline, but a still solid double digit year to date share price gain and a roughly 84% 5 year total shareholder return suggesting that longer term...
NasdaqGM:BLBD
NasdaqGM:BLBDMachinery

How Stronger Margins and Analyst Upgrades At Blue Bird (BLBD) Have Changed Its Investment Story

In recent days, Blue Bird reported robust quarterly results with higher revenue and net profit, alongside long-term sales growth and expanding margins that have supported renewed investor optimism. Analysts have responded with stronger positive ratings and outlooks, citing the company’s leadership in alternative-power school buses, a rebounding backlog, and improved operational efficiency. We’ll now examine how this improving analyst sentiment, supported by better margins and cash flow,...
NasdaqGS:AFRM
NasdaqGS:AFRMDiversified Financial

Why Affirm (AFRM) Is Up 16.1% After Renewing Its Amazon BNPL Deal Through 2031

Earlier in December, Affirm Holdings renewed its buy-now-pay-later agreement with Amazon through January 2031 and expanded partnerships with Shopify in the U.K. and REVOLVE across Canada and the U.K., while management reported healthy holiday-quarter demand and stable delinquency trends. By publicly challenging third-party data pointing to weaker volumes and reiterating confidence in its credit performance, Affirm addressed key investor worries about the durability of its growth and risk...
NYSE:DV
NYSE:DVMedia

TikTok Attention Integration Could Be A Game Changer For DoubleVerify Holdings (DV)

On 10 December 2025, DoubleVerify announced that its DV Authentic Attention product is now integrated with TikTok as the first badged TikTok Marketing Partner solution for attention measurement, providing advertisers with direct, impression-level signals on exposure and engagement across formats, creatives and objectives. This move deepens DoubleVerify’s role inside a major social platform, giving advertisers new tools to diagnose creative fatigue, benchmark TikTok performance, and shift...
NasdaqGS:OMCL
NasdaqGS:OMCLMedical Equipment

Omnicell (OMCL) valuation check as new Titan XT automation platform targets healthcare growth

Omnicell (OMCL) just rolled out Titan XT, a new enterprise level automated dispensing system built on its OmniSphere cloud platform, and the launch is already reshaping how investors think about the stock. See our latest analysis for Omnicell. The launch of Titan XT coincides with Omnicell’s 30 day share price return of 30.11 percent and 90 day share price return of 51.10 percent, which signal rapidly building momentum. However, the 5 year total shareholder return of negative 60.02 percent...
NYSE:ABM
NYSE:ABMCommercial Services

ABM Industries (ABM): Reassessing Valuation After Earnings Miss, Margin Concerns and WGNSTAR Deal Fallout

ABM Industries (ABM) slid after its latest earnings update, as a headline miss on expectations and cautious commentary on margins and the WGNSTAR acquisition overshadowed decent revenue growth and a fresh dividend increase. See our latest analysis for ABM Industries. The latest pullback, including a 1 day share price return of minus 2.99% and year to date share price return of minus 17.51%, suggests sentiment has cooled despite solid earnings recovery, dividend growth and ongoing buybacks...
NYSE:HL
NYSE:HLMetals and Mining

Record Q3 Results And S&P MidCap 400 Inclusion Could Be A Game Changer For Hecla Mining (HL)

Hecla Mining recently hit a new 52-week high after reporting record Q3 2025 revenue, earnings, and cash flow, supported by very large year-to-date silver price gains and reduced leverage. The company’s addition to the S&P MidCap 400 Index and progress on projects such as Polaris and Midas highlight growing operational scale and exploration depth that could reshape how investors view its silver-focused portfolio. We’ll now examine how Hecla’s record earnings and S&P MidCap 400 inclusion may...
NasdaqGS:VRSN
NasdaqGS:VRSNIT

Will CEO D Bidzos’s Ongoing Stock Sales Reshape VeriSign’s (VRSN) Long‑Term Confidence Narrative?

On December 18, 2025, VeriSign’s Executive Chairman, President, and CEO D Bidzos sold 9,000 company shares, contributing to a year of substantial insider selling highlighted in recent SEC filings. These transactions, set against VeriSign’s role in operating critical internet infrastructure, draw attention to how leadership’s trading activity aligns with its long-term outlook on the core domain registry business. We’ll now explore how this pattern of insider selling, particularly by the CEO,...
NasdaqGS:TLN
NasdaqGS:TLNRenewable Energy

Will Talen’s New President and CFO Refocus TLN on Digital Infrastructure and Low-Carbon Power?

Earlier this month, Talen Energy reshaped its leadership structure by appointing former CFO Terry L. Nutt as President and naming Cole Muller as Chief Financial Officer, alongside a series of senior operational and development role changes to support its evolving power and infrastructure business. The extensive reallocation of responsibilities, from nuclear oversight and fleet operations to new generation asset development and data center strategy, signals a concerted push to align...
NYSE:ETSY
NYSE:ETSYMultiline Retail

Is Etsy’s Nearly US$1 Billion Buyback And Board Shift Reframing Its Investment Case (ETSY)?

Etsy, Inc. recently announced a new US$750 million share repurchase authorization, lifting its total approved buyback capacity to nearly US$1 billion and confirming Fred Wilson will become Lead Independent Director in January 2026 alongside a planned CEO transition. The combination of substantial buybacks and enhanced board oversight highlights Etsy’s emphasis on capital return and governance as it confronts slowing gross merchandise sales and buyer engagement. Now we’ll examine how Etsy’s...
NYSE:CFG
NYSE:CFGBanks

How Investors May Respond To Citizens Financial Group (CFG) Surging EPS Forecasts And Private Banking Momentum

Earlier this month, Citizens Financial Group reported that analysts expect its fiscal fourth-quarter 2025 diluted EPS to reach US$1.12, implying a very large year-over-year profit increase, after the bank topped Wall Street earnings estimates in each of the previous four quarters. The bank’s performance has been underpinned by expansion in its private bank and wealth franchise, strong capital markets activity, and tighter cost control supported by technology and private banking investments...
NasdaqCM:RGC
NasdaqCM:RGCPharmaceuticals

Does Regencell Bioscience (RGC) Face a Deeper Governance Test After Expanded DOJ and Law-Firm Scrutiny?

Earlier this year, Regencell Bioscience Holdings disclosed that the US Department of Justice had launched an investigation into trading of its shares and requested extensive operational, financial and accounting records, prompting the company to warn of potentially significant legal costs and penalties. The subsequent involvement of law firm Bronstein, Gewirtz & Grossman, LLC, which is examining potential claims on behalf of Regencell purchasers, adds another layer of legal uncertainty...
NYSE:PG
NYSE:PGHousehold Products

How Investors Are Reacting To Procter & Gamble (PG) Influencer Push And Leadership Transition

In recent days, Procter & Gamble’s Pantene brand expanded its influencer push by launching a limited‑edition “As seen in Alix’s Shower” Abundant & Strong kit with creator Alix Earle, while the company also confirmed the planned 2026 retirement of long‑time Health Care CEO Jennifer Davis. Together with prior announcements on European logistics expansion and portfolio pruning, these moves highlight how P&G is refining its brand reach while tightening its operational footprint. We’ll now...
NasdaqGS:INVA
NasdaqGS:INVAPharmaceuticals

How Investors May Respond To Innoviva (INVA) Winning FDA Approval For First-In-Class Gonorrhea Drug

Innoviva, Inc. recently received US FDA approval for NUZOLVENCE (zoliflodacin), a first-in-class, single-dose oral antibiotic to treat uncomplicated urogenital gonorrhea in adults and pediatric patients. This marks one of the first new FDA-approved treatments for gonorrhea in nearly twenty years, underscoring Innoviva’s role in addressing antibiotic resistance and unmet infectious disease needs. We’ll now explore how bringing a first-in-class, single-dose oral treatment for gonorrhea affects...
NYSE:CNM
NYSE:CNMTrade Distributors

Core & Main (CNM): Reassessing Valuation After Strong Q3 Results and Confident Growth Strategy Update

Core & Main (CNM) just checked several key boxes in its latest earnings update, pairing steady third quarter growth with a clear commitment to acquisitions, share buybacks and disciplined capital allocation. See our latest analysis for Core & Main. The stock has cooled slightly after the earnings pop, with a 1 month share price return of 18.01% and a 3 year total shareholder return of 181.16%. This suggests momentum is still firmly on Core & Main’s side. If this kind of steady execution...